completion

HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead

October 31, 2025 08:00 ET  | Source: HOOKIPA Pharma Inc. NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) --…

1 month ago

Diginex Announces Completion of Acquisition of Matter DK ApS, Strengthening Diginexs AI-driven ESG Data and Analytics Leadership

October 03, 2025 16:05 ET  | Source: Diginex Limited LONDON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX)…

2 months ago

JNH PRESS Holds Completion Ceremony for Second Plant, Accelerating Leadership in Global Innovative Press Technology

SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- JNH PRESS, a leading Korean press manufacturer, celebrated a major milestone with…

2 months ago

Enovix Announces Completion of Warrant Dividend Program

September 05, 2025 18:08 ET  | Source: Enovix Corporation Warrants Expired and Ceased Trading on Friday, August 29, 2025 Approximately…

3 months ago

StudyIn Announces Completion of its Transaction with SUN Education

LONDON, Sept. 3, 2025 /PRNewswire/ -- StudyIn, the world's most trusted higher education specialist, has announced the completion of its…

3 months ago

GENESIS MAGMA RACING PREPARES FOR TESTING AFTER COMPLETION OF FIRST GMR001 HYPERCAR CHASSIS

Genesis Magma Racing is in the final stages of preparation for the first test with the GMR-001 HypercarThe first of…

4 months ago

Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis

KOLKATA, India, July 28, 2025 /PRNewswire/ -- In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was…

4 months ago

Cango Inc. Announces Completion of Secondary Acquisition and Appointment of New Leadership Team

HONG KONG, July 23, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today announced its transformation into a global Bitcoin miner…

5 months ago

Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study

TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…

5 months ago

AB Science announces the successful completion of a EUR 1.925 million private placement

PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925 MILLION PRIVATE PLACEMENT Paris, July 8, 2025, 8am…

5 months ago